Core Scientific Statistics
Total Valuation
Core Scientific has a market cap or net worth of $3.79 billion. The enterprise value is $7.39 billion.
| Market Cap | 3.79B |
| Enterprise Value | 7.39B |
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Core Scientific has 322.24 million shares outstanding. The number of shares has increased by 6.57% in one year.
| Current Share Class | 321.97M |
| Shares Outstanding | 322.24M |
| Shares Change (YoY) | +6.57% |
| Shares Change (QoQ) | +44.16% |
| Owned by Insiders (%) | 1.73% |
| Owned by Institutions (%) | 109.82% |
| Float | 277.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 48.64 |
| PS Ratio | 6.40 |
| Forward PS | 3.76 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 8.35 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.49 |
| EV / EBITDA | 141.99 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.67
| Current Ratio | 0.67 |
| Quick Ratio | 0.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | 61.00 |
| Debt / FCF | n/a |
| Interest Coverage | -0.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -0.18% |
| Return on Invested Capital (ROIC) | -0.38% |
| Return on Capital Employed (ROCE) | -0.32% |
| Weighted Average Cost of Capital (WACC) | 16.96% |
| Revenue Per Employee | $1.82M |
| Profits Per Employee | -$341,960 |
| Employee Count | 325 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -103.90M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.06% in the last 52 weeks. The beta is 5.56, so Core Scientific's price volatility has been higher than the market average.
| Beta (5Y) | 5.56 |
| 52-Week Price Change | -46.06% |
| 50-Day Moving Average | 15.68 |
| 200-Day Moving Average | 19.51 |
| Relative Strength Index (RSI) | 37.79 |
| Average Volume (20 Days) | 18,347,646 |
Short Selling Information
The latest short interest is 76.63 million, so 23.78% of the outstanding shares have been sold short.
| Short Interest | 76.63M |
| Short Previous Month | 65.99M |
| Short % of Shares Out | 23.78% |
| Short % of Float | 27.66% |
| Short Ratio (days to cover) | 5.77 |
Income Statement
In the last 12 months, Core Scientific had revenue of $592.07 million and -$111.14 million in losses. Loss per share was -$0.35.
| Revenue | 592.07M |
| Gross Profit | 260.87M |
| Operating Income | -12.17M |
| Pretax Income | -212.31M |
| Net Income | -111.14M |
| EBITDA | 52.06M |
| EBIT | -12.17M |
| Loss Per Share | -$0.35 |
Balance Sheet
The company has $803.94 million in cash and $4.41 billion in debt, with a net cash position of -$3.60 billion or -$11.18 per share.
| Cash & Cash Equivalents | 803.94M |
| Total Debt | 4.41B |
| Net Cash | -3.60B |
| Net Cash Per Share | -$11.18 |
| Equity (Book Value) | -1.09B |
| Book Value Per Share | -3.39 |
| Working Capital | -685.06M |
Cash Flow
In the last 12 months, operating cash flow was $453.75 million and capital expenditures -$2.45 billion, giving a free cash flow of -$2.00 billion.
| Operating Cash Flow | 453.75M |
| Capital Expenditures | -2.45B |
| Depreciation & Amortization | 64.23M |
| Net Borrowing | 3.27B |
| Free Cash Flow | -2.00B |
| FCF Per Share | -$6.20 |
Margins
Gross margin is 44.06%, with operating and profit margins of -2.05% and -18.31%.
| Gross Margin | 44.06% |
| Operating Margin | -2.05% |
| Pretax Margin | -35.86% |
| Profit Margin | -18.31% |
| EBITDA Margin | 8.79% |
| EBIT Margin | -2.05% |
| FCF Margin | n/a |
Dividends & Yields
Core Scientific does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -6.57% |
| Shareholder Yield | -6.57% |
| Earnings Yield | -2.98% |
| FCF Yield | -52.71% |
Analyst Forecast
The average price target for Core Scientific is $28.48, which is 142.18% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $28.48 |
| Price Target Difference | 142.18% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (3Y) | 75.52% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Core Scientific has an Altman Z-Score of -0.58 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.58 |
| Piotroski F-Score | 3 |